Massimo Galli

Massimo Galli's AcademicInfluence.com Rankings

Massimo Galli

Philosophy

#7505

World Rank

#10728

Historical Rank

Logic

#4555

World Rank

#5865

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Massimo Galli's Degrees

Doctorate Medicine University of Milan
PhD Infectious Diseases University of Milan

Why Is Massimo Galli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Massimo Galli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 (2020) (1053)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study (2020) (960)
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study (2020) (726)
Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. (2020) (686)
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (2021) (443)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms (2020) (427)
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? (2020) (375)
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. (2012) (346)
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. (1999) (326)
Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. (1995) (256)
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. (1997) (236)
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study (2020) (215)
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (2020) (208)
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. (2011) (190)
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count (2011) (181)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study (2020) (181)
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. (2005) (178)
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status (2020) (177)
Early phylogenetic estimate of the effective reproduction number of SARS‐CoV‐2 (2020) (176)
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. (2019) (174)
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study (2020) (170)
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial (2021) (167)
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection (2021) (165)
Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists (2020) (164)
Relationship Between HAART Adherence and Adipose Tissue Alterations (2002) (163)
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy (2020) (160)
Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy (2020) (157)
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. (2015) (152)
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral‐experienced patients in advanced stages of HIV‐1 infection (1998) (150)
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART (2006) (150)
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 (2020) (145)
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. (2001) (143)
Candidemia and invasive candidiasis in adults: A narrative review. (2016) (139)
Preliminary classification criteria for the cryoglobulinaemic vasculitis (2011) (134)
Gender Differences in Antiretroviral Drug–Related Adipose Tissue Alterations: Women Are at Higher Risk Than Men and Develop Particular Lipodystrophy Patterns (2003) (134)
Chagas disease in Europe: A review for the internist in the globalized world. (2017) (128)
Cortisol resistance in acquired immunodeficiency syndrome. (1992) (126)
Genomic characterization and phylogenetic analysis of SARS‐COV‐2 in Italy (2020) (124)
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. (1985) (120)
Homozygous Δ32 deletion of the CCR‐5 chemokine receptor gene in an HIV‐1‐infected patient (1997) (116)
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing (2014) (112)
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC (2019) (111)
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. (1996) (110)
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. (2011) (110)
The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity (2020) (103)
Body Habitus Changes and Metabolic Alterations in Protease Inhibitor‐Naive HIV‐1‐Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors (2002) (100)
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. (1986) (99)
Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1 (2001) (98)
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak (2020) (94)
Secondary and Essential Cryoglobulinemias (1983) (94)
Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases (2012) (92)
Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. (2002) (92)
Ultrasound in medicine and biology. (1971) (91)
Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. (2012) (90)
Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART (2010) (89)
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. (1996) (88)
Disseminated human herpesvirus 6 infection In AIDS (1993) (88)
Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors (2000) (87)
Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. (2009) (86)
Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. (1997) (86)
THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME BEFORE AND DURING THE ERA OF INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (2002) (84)
The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). (1996) (82)
AIDS, zinc deficiency, and thymic hormone failure. (1988) (81)
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. (1996) (80)
Increased Mitochondrial Dna Content in Peripheral Blood Lymphocytes from HIV-Infected Patients with Lipodystrophy (2002) (76)
Direct‐acting antivirals in hepatitis C virus (HCV)‐infected and HCV/HIV‐coinfected patients: real‐life safety and efficacy (2017) (76)
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. (1997) (72)
High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. (2007) (70)
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. (2011) (70)
Eradication of a multi-drug resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom-made, lytic bacteriophage preparation. (2020) (69)
Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients (2006) (67)
Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? (2014) (67)
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties (2020) (66)
Validation of the classification criteria for cryoglobulinaemic vasculitis. (2014) (66)
Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. (2011) (66)
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. (2002) (65)
Weight Gain: A Possible Side Effect of All Antiretrovirals (2017) (65)
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment (2013) (63)
Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades * (2010) (62)
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey (2020) (62)
Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. (2016) (62)
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening (2020) (62)
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper. (2017) (61)
AIDS‐associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre‐ and post‐HAART eras. Experience of a single centre in Italy (2009) (59)
CD4 cell counts at the third month of HAART may predict clinical failure. (1999) (58)
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy (2008) (58)
Spatial and Temporal Dynamics of Hepatitis B Virus D Genotype in Europe and the Mediterranean Basin (2012) (58)
Prevalence of Transmitted Nucleoside Analogue-Resistant HIV-1 Strains and Pre-Existing Mutations in Pol Reverse Transcriptase and Protease Region: Outcome after Treatment in Recently Infected Individuals (2000) (58)
Chemokine production in HIV-seropositive long-term asymptomatic individuals. (1996) (58)
Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. (1997) (57)
Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. (2006) (55)
Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. (2000) (55)
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. (2010) (55)
Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects. (2012) (54)
Absence of HHV-8 in prostate and semen. (1996) (53)
Late Presenters in New HIV Diagnoses from An Italian Cohort of HIV-Infected Patients: Prevalence and Clinical Outcome (2011) (53)
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV‐1 infection (1996) (53)
Trends and Predictors of Non–AIDS-Defining Cancers in Men and Women With HIV Infection: A Single-Institution Retrospective Study Before and After the Introduction of HAART (2013) (52)
Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events (2013) (51)
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes (2001) (51)
The pavia consensus statement. (2003) (51)
Population Dynamics of HIV-1 Subtype B in a Cohort of Men-Having-Sex-With-Men in Rome, Italy (2010) (48)
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic (2020) (48)
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals (2015) (48)
Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. (2011) (48)
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV coinfected patients (2009) (48)
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy (2020) (46)
Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. (2002) (46)
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. (1995) (45)
Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography (2017) (44)
Mortality of intravenous drug users living in Milan, Italy: role of HIV‐1 infection (1994) (44)
Immunoendocrinologic Abnormalities in Human Immunodeficiency Virus Infection (2000) (44)
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial (2015) (43)
[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. (2005) (43)
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement (2020) (42)
Origin, evolution, and phylogeography of recent epidemic CHIKV strains. (2012) (41)
Hepatitis C virus and mixed cryoglobulinaemias (1992) (41)
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. (2010) (41)
Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. (2008) (40)
Prevalence and outcome of silent hypoxemia in COVID-19. (2021) (39)
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study. (2015) (39)
Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. (1983) (39)
Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C. (1995) (39)
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. (1997) (38)
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion (2020) (38)
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. (1999) (38)
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases (2012) (38)
Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience (2020) (38)
Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. (1988) (37)
HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. (1990) (36)
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study (2014) (36)
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. (2012) (35)
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. (2014) (34)
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015. (2016) (34)
Increased Risk of Developing Peripheral Neuropathy in Patients Coinfected With HIV‐1 and HTLV‐2 (2002) (34)
Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature (2014) (34)
Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy (2013) (33)
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics (2004) (33)
Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. (2012) (33)
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey (2020) (33)
The syndrome of acquired glucocorticoid resistance in HIV infection. (1994) (32)
Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Raltegravir in HIV Patients Receiving the Drug by Swallowing or by Chewing (2012) (32)
Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy (2021) (32)
Compartmentalization of Hepatitis C Virus Quasispecies in Blood Mononuclear Cells of Patients with Mixed Cryoglobulinemic Syndrome (2005) (32)
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study (2017) (32)
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan. (2021) (31)
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. (2012) (31)
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. (2000) (31)
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial (2018) (31)
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). (2017) (31)
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART (2010) (30)
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) (2020) (30)
Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC). (1992) (30)
Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease (2020) (29)
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. (2012) (29)
Phylogeography and phylodynamics of European genotype 3 hepatitis E virus. (2014) (29)
Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected Patients (2011) (29)
Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages? (2015) (28)
Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe (2013) (28)
HIV type 1 phenotype correlates with the stage of infection in vertically infected children. (1996) (28)
Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014 (2014) (28)
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study. (2010) (28)
Immunological status in heroin addicts: effects of methadone maintenance treatment. (1984) (28)
Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections (2000) (28)
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group (2021) (27)
Heterogeneity of COVID-19 outbreak in Italy (2020) (27)
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 (2021) (27)
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings (2020) (27)
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement (2020) (27)
High prevalence of human T‐lymphotropic virus type 1 (HTLV‐1) in immigrant male‐to‐female transsexual sex workers with HIV‐1 infection (2004) (27)
PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response (2021) (27)
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study (2020) (27)
Long-term efficacy of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy (2004) (26)
Optimization of hepatitis C virus screening strategies by birth cohort in Italy (2020) (26)
Evolutionary Dynamics of the Lineage 2 West Nile Virus That Caused the Largest European Epidemic: Italy 2011–2018 (2019) (26)
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. (1997) (25)
Persisting HIV-1 Replication Triggered by Acute Hepatitis a Virus Infection (2000) (25)
Reliable timescale inference of HBV genotype A origin and phylodynamics. (2015) (25)
Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey. (2020) (25)
Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. (2011) (25)
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. (2020) (25)
Does lopinavir really inhibit SARS-CoV-2? (2020) (25)
Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region. (2013) (24)
Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy. (2008) (24)
Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale (2021) (24)
Human herpesvirus-8 in AIDS-related and unrelated lymphomas. (1996) (24)
Virologic and immunologic markers of disease progression in pediatric HIV infection. (1996) (24)
INOSIPLEX IN RECURRENT HERPES SIMPLEX INFECTIONS (1982) (24)
Increased CD36 Expression on Circulating Monocytes During HIV Infection (2005) (23)
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates. (2004) (23)
Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats. (2004) (23)
HEPATITIS B VIRUS AND ESSENTIAL MIXED CRYOGLOBULINÆMIA (1980) (23)
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients (2017) (23)
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study (2020) (23)
Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey. (2011) (23)
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study (2018) (23)
Phylogeographic reconstruction of HIV type 1B in Montenegro and the Balkan region. (2012) (22)
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients. (2018) (22)
Cardiovascular Disease Risk Factors in HIV‐Infected Patients in the HAART Era (2001) (22)
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome. (2019) (22)
The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia (2020) (22)
Rapid molecular evolution of human bocavirus revealed by Bayesian coalescent inference. (2010) (22)
High frequency of non-Hodgkin's lymphoma in patients with HIV-associated Kaposi's sarcoma (1996) (22)
Clinical and immunological aspects of HIV infection in drug addicts. (1989) (22)
Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy (2021) (22)
Gastrointestinal basidiobolomycosis: An emerging mycosis difficult to diagnose but curable. Case report and review of the literature. (2019) (21)
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study (2018) (21)
Human T-Lymphotropic Virus Type 2 (HTLV-2) Provirus in Circulating Cells of the Monocyte/Macrophage Lineage in Patients Dually Infected with Human Immunodeficiency Virus Type 1 and HTLV-2 and Having Predominantly Sensory Polyneuropathy (1998) (21)
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus (2018) (21)
Effect of Cobicistat on Tenofovir Disoproxil Fumarate (TDF): What Is True for TAF May Also Be True for TDF (2017) (21)
Telbivudine in the Treatment of Chronic Hepatitis B: Experience in HIV Type-1-Infected Patients Naive for Antiretroviral Therapy (2009) (20)
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms. (2008) (20)
Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men. (2014) (20)
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. (2018) (20)
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial. (1997) (20)
Correlates of Risk of Adipose Tissue Alterations and Their Modifications over Time in HIV-1-Infected Women Treated with Antiretroviral Therapy (2002) (20)
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. (2007) (20)
Hepatitis B virus genotype distribution in HIV-1 coinfected patients. (2003) (20)
Tracheoesophageal fistula in an HIV-1-positive man due to dual infection of Candida albicans and cytomegalovirus. (1994) (20)
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children. (1997) (20)
Description of a “Trans-Saharan” Strain of Human T-Lymphotropic Virus Type 1 in West Africa (2008) (20)
Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: the DHIVA study (2015) (19)
Pandemic influenza vaccine in adult HIV-1-infected patients. (2010) (19)
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population (2020) (19)
High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy. (2015) (19)
Risk factors for HIV/AIDS in a low HIV prevalence site of sub‐Saharan Africa (2007) (19)
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy (2010) (19)
High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients. (1997) (19)
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients. (2003) (19)
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. (2013) (18)
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy (2013) (18)
ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP (2003) (18)
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers. (2012) (18)
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. (2010) (18)
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. (2017) (18)
Reconstruction of the Evolutionary Dynamics of the A(H1N1)pdm09 Influenza Virus in Italy during the Pandemic and Post-Pandemic Phases (2012) (18)
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) (2007) (18)
Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of In Vitro Lamivudine Drug Pressure (1998) (17)
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). (2015) (17)
No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia. (1996) (17)
One year of anatomy teaching and learning in the outbreak: Has the Covid‐19 pandemic marked the end of a century‐old practice? A systematic review (2021) (17)
Myasthenia gravis with a monoclonal gammopathy Report of a case (1980) (16)
HTLV infection in ELISA-negative blood donors. (1996) (16)
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study (2019) (16)
Retrobulbar optic neuritis in a patient with acute type B hepatitis (1986) (16)
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy (2018) (16)
T-cell subsets and serum immunoglobulin levels in infants born to HIV-seropositive mothers: a longitudinal evaluation. (1990) (16)
Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine (2021) (16)
CD4 count in HIV infection is positively correlated to interferon-gamma and negatively correlated to interleukin-10 in vitro production. (1996) (16)
Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein. (2001) (15)
Molecular epidemiology of TT virus in Italy and phylogenesis of viral isolates from subjects at different risk for parenteral exposure (2001) (15)
Lung ultrasonography in pulmonary tuberculosis: A pilot study on diagnostic accuracy in a high-risk population. (2019) (15)
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. (2015) (15)
Changes in the Incidence of Severe Thrombocytopenia and Its Predisposing Conditions in HIV-Infected Patients Since the Introduction of Highly Active Antiretroviral Therapy (2014) (15)
HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. (1995) (15)
In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure (2001) (15)
Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts. (1997) (15)
Thalidomide in the Treatment of Chronic Hepatitis C Unresponsive to Alfa-Interferon and Ribavirin (2006) (15)
Severe Plasmodium falciparum malaria in the intensive care unit: A 6-year experience in Milano, Italy. (2017) (15)
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. (2017) (15)
Cryoglobulinaemia and serological markers of hepatitis viruses (1991) (15)
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens. (2011) (15)
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. (2020) (15)
Epidemiological trends of infective endocarditis in a single center in Italy between 2003–2015 (2018) (14)
Dolutegravir Plasma Concentrations According to Companion Antiretroviral Drug: Unwanted Drug Interaction or Desirable Boosting Effect? (2017) (14)
Immune complexes in leptospirosis (1985) (14)
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation. (2007) (14)
Retinal vessels modifications in acute and post-COVID-19 (2021) (14)
HIV‐infected long‐term nonprogressors display a unique correlative pattern between the interleukin‐7/interleukin‐7 receptor circuit and T‐cell homeostasis (2009) (14)
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation. (2021) (14)
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results. (1985) (14)
Il-7/Il-7 Receptor System Regulation following Il-2 Immunotherapy in HIV-Infected Patients (2003) (14)
Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey (2021) (14)
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort. (2019) (13)
Low CD4 counts rather than superantigenic‐like effects account for differences in expressed T‐cell receptor (TCR) repertoires between HIV‐1 seropositive long‐term non‐progressors and individuals with progressive disease (1998) (13)
Controversy concerning role of ultrasonographic lipoatrophy assessments in HIV patients. (2006) (13)
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy (2020) (13)
Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey (2021) (13)
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis. (2017) (13)
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals. (2001) (13)
Fat Redistribution in HIV‐Infected Patients: A New Hormonal‐Immune Disorder? (2000) (13)
Frequent detection of antibodies against HTLV antigens in patients with AIDS-related non-Hodgkin lymphoma. (1995) (13)
Physicians’ Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease (2019) (13)
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? (2020) (13)
Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals. (2012) (13)
Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors. (2002) (13)
Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy (2009) (13)
Viruses and cryoglobulinemia. (1995) (13)
Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy (2021) (13)
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy (2000) (13)
Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression. (2012) (13)
Soluble HIV suppressive factors: more than one Holy Grail? (1996) (13)
Diffusion and transmission of carbapenem-resistant Klebsiella pneumoniae in the medical and surgical wards of a university hospital in Milan, Italy. (2016) (13)
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons (2018) (12)
Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d’Adda, Italy (2020) (12)
Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau. (2010) (12)
A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients (2013) (12)
Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility. (2004) (12)
Body habitus alterations in HIV-infected women treated with combined antiretroviral therapy. (2000) (12)
Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection. (2018) (12)
Absence of Kaposi's sarcoma--associated herpesvirus DNA sequences in multiple myeloma. (1999) (12)
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering. (1999) (11)
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC) (2021) (11)
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group (2013) (11)
Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan, Italy (2017) (11)
Serum 2'-5'-oligoadenylate synthetase levels and clinical response to interferon-beta therapy in women with genital human papillomavirus infection. (1994) (11)
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience (2018) (11)
Clinical and genetic determinants of nevirapine plasma trough concentration (2018) (11)
Immunomodulation Induced by Tucaresol in HIV Infection: Results of a 16 Week Pilot Phase I/II Trial (2004) (11)
Durability of Lopinavir/Ritonavir Monotherapy in Individuals with Viral Load ≦50 Copies/Ml in an Observational Setting (2014) (11)
Hepatitis B virus and cryoglobulinemia. (1981) (11)
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients (2017) (11)
Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA). (2020) (11)
Rapid spread of HIV infection in a rural district in central Africa. (1988) (10)
Early Phylogenetic Estimate Of The Effective Reproduction Number Of 2019-nCoV (2020) (10)
Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon? (2020) (10)
Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV‐coinfected patients (2009) (10)
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets. (2022) (10)
Chagas disease knocks on our door: a cross-sectional study among Latin American immigrants in Milan, Italy. (2018) (10)
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART (2018) (10)
Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. (2012) (10)
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. (2012) (10)
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy (2018) (10)
Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study (2020) (10)
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service (2014) (10)
Is imported onchocerciasis a truly rare entity? Case report and review of the literature. (2017) (10)
Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting (2003) (10)
SARS‐CoV‐2 reinfection in a cancer patient with a defective neutralizing humoral response (2021) (10)
Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV-positive woman with highly active antiretroviral therapy-associated massive breast enlargement. (2002) (10)
Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users. (1998) (10)
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis (2019) (9)
Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine. (1991) (9)
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). (2006) (9)
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy (2022) (9)
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. (1999) (9)
Sonographic assessment of lipodystrophy in HIV-infected patients: some open questions. (2005) (9)
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. (2014) (9)
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. (2019) (9)
HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunity. (2008) (9)
CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy. (1999) (9)
Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT) (2014) (9)
Missed Opportunities of Flu Vaccination in Italian Target Categories: Insights from the Online EPICOVID 19 Survey (2020) (8)
Hepatitis B virus and essential mixed cryoglobulinaemia. (1980) (8)
Knowledge, attitudes and practice (KAP) regarding newborn feeding modalities in HIV-infected and HIV-uninfected pregnant women in sub-Saharan Africa: a multicentre study. (2011) (8)
Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts. (1987) (8)
When food can make the difference: The case of elvitegravir-based co-formulation. (2016) (8)
Vaccinations in patients with inflammatory bowel disease. (2021) (8)
In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs (1999) (8)
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS). (1986) (8)
Thymostimulin treatment in AIDS-related complex. (1988) (8)
Evolocumab in HIV-Infected Patients With Dyslipidemia (2020) (8)
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL. (2019) (8)
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice (2018) (8)
Pain management in cryoglobulinaemic syndrome. (2015) (8)
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people. (1996) (8)
The cryoglobulinemic syndrome (1986) (8)
CMV co‐infection and risk of AIDS and non‐AIDS events in a large cohort of HIV‐infected patients (2012) (8)
Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases. (2020) (8)
Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV‐1 infection (2006) (8)
Reconstruction of the Evolutionary Dynamics of A(H3N2) Influenza Viruses Circulating in Italy from 2004 to 2012 (2015) (8)
Hepatitis B virus genotype and subgenotype prevalence and distribution in Montenegro (2015) (8)
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes. (2022) (8)
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. (2008) (8)
Massive viral replication and cytopathic effects in early COVID-19 pneumonia (2020) (8)
Current smoking and SARS-CoV-2 infection: findings from the Italian cross-sectional EPICOVID19 internet-based survey. (2021) (8)
Trends in hospital admissions at a Department for Infectious Diseases in Italy from 1995 to 2011 and implications for health policies (2014) (8)
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities. (2020) (8)
Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women. (2013) (7)
Drug-induced liver steatosis in patients with HIV infection. (2019) (7)
Virological Response in Multidrug-Experienced HIV-1-Infected Subjects Failing Highly Active Combination Regimens after Shifting from Lamivudine to Didanosine (2001) (7)
Alexander the Great and West Nile virus encephalitis. (2004) (7)
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) (2020) (7)
Prevalence of HIV-1 resistant strains in recent seroconverters. (2000) (7)
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population (2012) (7)
Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication (2017) (7)
Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma? (2004) (7)
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study. (2014) (7)
Comparability of echographic and tomographic assessments of body fat changes related to the HIV associated adipose redistribution syndrome (HARS) in antiretroviral treated patients. (2008) (7)
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015. (2017) (7)
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History (2021) (7)
Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy. (2008) (7)
Stratification of the risk of developing severe or lethal Covid-19 using a new score from a large Italian population: a population-based cohort study (2021) (7)
Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases (2018) (6)
Treatment of Recurrent Viral Infectious Diseases by Methisoprinol (1984) (6)
Health technology assessment in the HIV setting: the case of monotherapy. (2014) (6)
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. (2014) (6)
Phylogeny of human T cell lymphotropic virus type 1 in Peru: a high degree of evolutionary relatedness with South African isolates. (2007) (6)
Cryoglobulins and infectious diseases (1986) (6)
DASABUVIR AND OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HIV-HCV COINFECTION: REAL LIFE INTERIM ANALYSIS OF AN ITALIAN MULTICENTRE COMPASSIONATE USE PROGRAM (2016) (6)
EPICOVID19: Psychometric assessment and validation of a short diagnostic scale for a rapid Covid-19 screening based on reported symptoms (2020) (6)
Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy (2021) (6)
Attempted treatment of fulminant viral hepatitis with human fibroblast interferon (1985) (6)
Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature. (2020) (6)
Pulmonary candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis. (1985) (6)
HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. (1995) (6)
In vitro anti‐HIV‐1 antibody production in subjects in different stages of HIV‐1 infection (1995) (6)
Causes of death in essential mixed cryoglobulinemia (1986) (6)
Visceral leishmaniasis in HIV infection: a report of three cases. (1989) (6)
Transient symptomatic cryoglobulinemia in gram-negative bacteria infections. (1984) (6)
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice (2016) (6)
Non-Human Primate and Human Malaria: Past, Present and Future. (2021) (6)
Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study (2022) (6)
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate. (1997) (6)
Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach. (2020) (6)
Lung ultrasound in the management of pneumocystis pneumonia: A case series (2018) (6)
Is human herpesvirus type 8 fairly prevalent among healthy subjects in Italy? (1996) (6)
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years. (2009) (6)
Bayesian reconstruction of the evolutionary history and cross‐species transition of variola virus and orthopoxviruses (2018) (6)
Absence of circulating interferon in acute viral hepatitis. (1984) (5)
Opera: Use of Pegylated Interferon plus Ribavirin for Treating HCV–HIV Coinfection in Interferon-Naive Patients (2014) (5)
Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis? (2013) (5)
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan (2020) (5)
Dynamics of the SARS-CoV-2 epidemic in the earliest-affected areas in Italy: 1 Mass screening for SARS-CoV-2 serological positivity (SARS-2-SCREEN). (2020) (5)
Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART. (2021) (5)
Persistence of Long-COVID symptoms in a heterogenous prospective cohort (2022) (5)
Sofosbuvir/Ribavirin treatment in patients with genotype 2, Hepatitis C Virus infection and symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life (2017) (5)
Distribution of Marburg virus in Africa: An evolutionary approach. (2016) (5)
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases. (2020) (5)
Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic (2021) (5)
Epidemiological and clinical characteristics of imported malaria in adults in Milan, Italy, 2010-2015. (2018) (5)
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation. (1999) (5)
Predictive Value of Prostate Specific Antigen in a European HIV-positive Cohort: Does One Size Fit All? (2016) (5)
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014. (2015) (5)
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy (2021) (5)
OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study (2014) (5)
New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses† (2009) (5)
Frequency of Pancreatic Hyperamylasemia in Human Immunodeficiency Virus-Positive Patients in the Highly Active Antiretroviral Therapy Era. (2016) (5)
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry (2022) (5)
Mycosis fungoides with mixed cryoglobulinemia and pulmonary vasculitis. A case report. (1987) (5)
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study (2021) (5)
Predicting Severe/Critical Outcomes in Patients With SARS-CoV2 Pneumonia: Development of the prediCtion seveRe/crItical ouTcome in COVID-19 (CRITIC) Model (2021) (4)
Increased CD36 expression in vertically human immunodeficiency virus-infected children unrelated to antiretroviral therapy. (2005) (4)
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 (2021) (4)
Lymph node finding in drug abusers. (1984) (4)
Immune response in a symptomatic case of Tetrapetalonema perstans infection. (1984) (4)
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? (2019) (4)
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy (2022) (4)
Time-scaled phylogeography of complete Zika virus genomes using discrete and continuous space diffusion models. (2019) (4)
Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects (2019) (4)
Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis. (2020) (4)
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts. (1988) (4)
Tubercular gluteus abscesses: a return to the early 20th century or a consequence of new, unprecedented behaviors? (2011) (4)
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference? (2021) (4)
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir. (2008) (4)
SARS-COV-2 infection: Across the border into the family (2020) (4)
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. (1998) (4)
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon‐naïve patients with HIV/HCV genotype 2/3 co‐infection in Italy (2015) (4)
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis. (2021) (4)
Factors involved in continuance of atazanavir-based regimens: Results from a cohort of HIV1-positive patients. (2016) (4)
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology. (2014) (4)
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study. (2020) (4)
Liver-related death among HIV/HCV coinfected indivi duals, implications for the era of directly acting ant ivirals (2014) (4)
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors. (1997) (3)
A review of Chagas disease in Italy and the study's contribution of Italian researchers. (2020) (3)
Epidemiological aspects of HTLV-III infection in Italy (1985) (3)
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen. (2001) (3)
Potential Association between Rosuvastatin use and High Atazanavir trough Concentrations in Ritonavir-Treated HIV-Infected Patients (2015) (3)
Proven intra and interobserver reliability in the echographic assessments of body fat changes related to HIV associated Adipose Redistribution Syndrome (HARS). (2008) (3)
Cryoglobulinemia and liver involvement (1986) (3)
Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals. (1998) (3)
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI (2014) (3)
548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19 (2020) (3)
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. (2018) (3)
Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients (2008) (3)
A new predictive model for an improved respiratory isolation strategy in HIV-infected patients with PTB. (2014) (3)
Mycobacterium avium Subspecies paratuberculosis Bacteremia in Type 1 Diabetes Mellitus : An Infectious Trigger ? (3)
Phylogeographical and evolutionary history of variola major virus; a question of timescales? (2020) (3)
Dating the origin and dispersal of Human Papillomavirus type 16 on the basis of ancestral human migrations. (2016) (3)
Are Epidemiological Estimates Able to Describe the Ability of Health Systems to Cope with COVID-19 Epidemic? (2021) (3)
Brachial paresis complicating acute non-A, non-B hepatitis. (1984) (3)
QT Interval Monitoring and Drugs Management During COVID-19 Pandemic. (2020) (3)
Lymphocyte subpopulations and surface membrane immunoglobulins in myasthenia gravis. (1982) (3)
Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort (2014) (3)
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID‐19 (2022) (3)
HCV point of care screening in people tested for SARS‐CoV‐2 in a social‐housing neighbourhood of Milan, Italy (2022) (3)
Influenza Vaccination Uptake in the General Italian Population during the 2020–2021 Flu Season: Data from the EPICOVID-19 Online Web-Based Survey (2022) (3)
Structural skull defects in type IV Ehlers‐Danlos syndrome (1984) (3)
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease. (2020) (2)
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis (2019) (2)
Italian multicentre study of didanosine compassionate use in advanced HIV infection (1997) (2)
Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan (1984) (2)
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+ subpopulation. (1996) (2)
Decreased chloroquine sensitivity of Plasmodium falciparum in two Italian travellers from Madagascar. (1984) (2)
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in a large Italian resistance database (ARCA). (2013) (2)
Definition of the Immune Parameters Related to COVID-19 Severity (2022) (2)
Epidemiology of SARS-CoV-2 infection in Italy using real-world data: methodology and cohort description of the second phase of web-based EPICOVID19 study. (2022) (2)
KSHV reactivation in post-transplant Kaposi sarcoma (2003) (2)
Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Phase 1 Study (2015) (2)
Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results. (2011) (2)
GB Virus C Infection in Patients with Type II Cryoglobulinemia (1998) (2)
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice (2014) (2)
Epidemic of LAV/HTLV III infection in drug addicts in milan: Serological survey and clinical follow-up (1985) (2)
Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar (2017) (2)
Evidence of SARS-CoV-2 Antibodies and RNA on Autopsy Cases in the Pre-Pandemic Period in Milan (Italy) (2022) (2)
Humoral immune responses in human loaiasis. (1982) (2)
Telemedicine for Africa : collaborative action between Italy and Swaziland against HIV infection (2)
Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy. (1986) (2)
Generics for the Treatment of Hepatitis C in Monoinfected and HIV-coinfected Patients: Pros and Cons. (2017) (2)
Viral antibodies in serum and cryoprecipitate of patients with essential mixed and secondary cryoglobulinemia preliminary results (1986) (2)
Delayed-type hypersensitivity skin testing can predict CD4 count increase in HIV patients with poor immunologic response to HAART. (2003) (2)
Cryoglobulinaemia in a patient with proteus mirabilis sepsis (1982) (2)
Natural killer cytotoxic test in the presence of phytohemagglutinin distinguishes between patients in the early and late stages of human immunodeficiency virus infection. (1991) (2)
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis. (2022) (2)
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial (2015) (2)
Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation. (2010) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
[Humoral immunity profile in idiopathic paralysis of the VIIth cranial nerve]. (1983) (2)
HIV policy in Italy and recommendations across the HIV care continuum. (2020) (1)
72. Remdesivir vs Standard Care in Patients with Moderate covid-19 (2020) (1)
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study (2021) (1)
Lymphoma Prevalence in Patients with Serum Cryoglobulins with or without Cryoglobulinemic Vasculitis: Data Extrapolated From the Cryoglobulinemic Vasculitis Classification Criteria Database. (2011) (1)
An Italian multicenter controlled study of HCV-related malignancies: Role of the HLA class II (2006) (1)
From Clinical Specimen to Whole Genome Sequencing of A(H3N2) Influenza Viruses: A Fast and Reliable High-Throughput Protocol (2022) (1)
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus. (2014) (1)
Immunological features of nonhealing midline granuloma. (1986) (1)
Chronic granulomatous disease in a 23-year-old female. (1986) (1)
Peripheral blood lymphocyte proliferation specific for HTLV-Tax peptides in enzyme-linked immunosorbent assay-negative HTLV DNA-positive blood donors. (2000) (1)
HCV-Negative Mixed Cryoglobulinemia: Facts and Fancies (2012) (1)
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) (2022) (1)
Defect of leukocyte functions and circulating immune complexes in visceral leishmaniasis. (1985) (1)
OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins (2015) (1)
Atazanavir-Induced Severe Episodes of Kidney Stones in an HIV-1-Infected Subject Characterized by a CYP3A Poor Metabolizer Phenotype (2014) (1)
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol. (2005) (1)
Time and Mode of Epidemic HCV-2 Subtypes Spreading in Europe: Phylodynamics in Italy and Albania (2021) (1)
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy. (2005) (1)
Analysis of the role of Chest X-Ray in a large cohort of 1117 patients with SARS-CoV-2 infection: an Italian multicenter study (2020) (1)
Critically ill patients at risk of invasive candidiasis: The "dilemma" of the best antifungal treatment strategy. (2017) (1)
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey (Preprint) (2020) (1)
Adipose tissue alterations after starting antiretroviral therapy in naive patients: the LiplCONA study (2000) (1)
Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine (1998) (1)
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. (2021) (1)
Changes in CD4+ cells’ miRNA expression following exposure to HIV-1 (2010) (1)
Specific IgE response in dracunculiasis. (1985) (1)
Maintenance of naive and Th1 CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens. (2001) (1)
The AIDS epidemic. (1995) (1)
Impairment ofpolymorphonuclear leucocyte function inpatients withacquired immunodeficiency syndrome andwithlymphadenopathy syndrome (1986) (1)
ABC of AIDS: Treatment of infections and antiviral agents (1987) (1)
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study (2014) (1)
INOSIPLEX IN RECURRENT HERPES SIMPLEX INFECTION (1982) (1)
Dxn Veris System for HCV Viral Load Monitoring in the Era of Second wave Direct-Acting Antiviral Agents (2016) (1)
The Milano Sforza Registers (2021) (1)
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of HIV-1 unique recombinant forms (2008) (1)
Beyond Italian guidelines in the management of HIV-positive patient. (2020) (1)
Strenuous resistance to natural HIV-1 disease progression: viral controllers and long-term nonprogressors (2011) (1)
Polymorphonuclear leucocyte function during acute viral hepatitis. (1984) (1)
Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study (2022) (0)
[Generalized and persistent lymphadenopathy in drug addicts: clinical and epidemiological aspects]. (1984) (0)
Sniffer dogs performance is stable over time in detecting COVID-19 positive samples and agrees with the rapid antigen test in the field (2023) (0)
A spatio-temporal reconstruction of the 1630 plague epidemic in Milan (2023) (0)
Anti-HIV-1 Intermittent Drug Intensification in HIV-1-Infected Patients Naive for Antiretrovirals (1998) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial. (2018) (0)
The Plague of 1630 in Milan: Did the Procession with the Body of San Carlo Play a Role in Spreading the Epidemic? (2022) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
Reply to: "Multi-dermatomal herpes zoster in a young patient with Crohn's disease on thiopurine therapy: Need for reconsidering vaccine recommendations". (2022) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
The Predictive Role of Circulating Serum Free Light Chains (sFLC) in HIV Associated Non Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD) and Its Correlation with Effective Combined Antiretroviral Treatment (cART) (2010) (0)
The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2, Necroptosis, Pyroptosis and Panoptosis (2022) (0)
Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale (Preprint) (2020) (0)
Pneumocystis carinii pneumonia after the discontinuation of long-term antiretroviral therapy in an HIV-1-infected pregnant woman. (2003) (0)
Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey (Preprint) (2021) (0)
Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform (2022) (0)
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) (2022) (0)
Incidence and Characteristics of Non-Hodgkin’s Lymphomas in HCV-Positive Patients with Mixed Cryoglobulinemia (2012) (0)
Seroprevalence of SARS-CoV-2 IgG significantly varies with age : results from a mass 6 population screening ( SARS-2-SCREEN-CdA ) 7 8 (2020) (0)
Inhibitors Multidrug Resistance to Other Protease Isolates Derived from Patients with Human Immunodeficiency Virus Type 1 Susceptibility to PNU-140690 (Tipranavir) of (2014) (0)
Physicians’ and patients’ perception of adipose tissue alterations changes according to the management strategy (2002) (0)
Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014 (2014) (0)
The value of lamp to rule out imported malaria diagnosis: a retrospective observational study in Milan, Italy (2022) (0)
HBV Virus in the Future (2016) (0)
Track B Clinical Science (2012) (0)
538 Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospital during COVID-19 pandemic in Italy (2021) (0)
[In vivo interferon-inducing capacity of a multibacterial extract: prospective new use]. (1984) (0)
In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients. (1997) (0)
OC-34 OPERA: the use of Pegylated interferon and ribavirin for the treatment of HCV/HIV coinfection in interferon-naïve patients in Italy (2013) (0)
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 (2021) (0)
High prevalence of antibodies directed against HTLV-I/II antigens in HIV-1 infected patients with non-hodgkin lymphoma (2007) (0)
HCV and drug addiction in the historical scenario of infection entry in Italy (2018) (0)
Is there a role for procalcitonin determination in avoiding unnecessary exposure to antibiotics in a non-intensive care setting? (2019) (0)
[Mixed cryoglobulinemias and liver diseases]. (1982) (0)
SAT0175 Results of the Classification Criteria for Cryoglobulinemic Vasculitis Validation Study (2013) (0)
Primary HIV Infection in Patients with Acute Hepatitis B: A Report of Two Cases (2018) (0)
Peripheral blood pre-erythroidal cells in HIV-1 infection (2015) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
THU0294 THE DIFFERENCES IN THE CLINICAL SPECTRUM OF CRYOGLOBULINEMIC VASCULITIS BETWEEN SJÖGREN’S SYNDROME AND HCV HEPATITIS (2020) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Tuberculous meningitis in a patientwith acute human immunodeficiencyvirus infection (2010) (0)
WNV in Italia : probabili multiple introduzioni di ceppi differenti (2014) (0)
Are health indicators able to describe the ability to cope of Health Systems with COVID-19 epidemic? (2020) (0)
Assessment for sonographic grading scales of the body fat changes related to the lipoatrophic findings of HIV patients in treatment with HAART (2008) (0)
Comment on: Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. (2017) (0)
850 IN VIVO EVALUATION OF ANTI-HCV ACTIVITY OF FLUVASTATIN: A PILOT STUDY (2008) (0)
Type-2 cytokine profile and T-lymphocyte activation in recently seroconverted HIV-1-infected subjects (1995) (0)
Prevalence of Borrelia burgdorferi antibodies in Bell's palsy in a metropolitan area of northern Italy. (1994) (0)
Title: Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a 1 mass population screening (2020) (0)
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting (2010) (0)
HCV and immigration in Italy (2018) (0)
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV‐infected patients (2012) (0)
Monoclonal antibody-defined T lymphocyte subpopulations in monoclonal gammapathy of undetermined significance (1987) (0)
Significant decrement of HIV-1RNA values during the first 30 days of zidovudine therapy in HIV-1-infected patients naive for antiretroviral treatment (1997) (0)
T lymphocyte subpopulations defined by monoclonal antibodies in essential mixed cryoglobulinemia and in secondary cryoglobulinemias (1986) (0)
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART (2010) (0)
Evolution of Resistance-Associated Variants of All-Oral Direct-Acting Antiviral Therapy of Hepatitis C in a Clinical Setting (2017) (0)
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME (2019) (0)
Is HAART based on newest active antiretroviral drugs influenced by GSS? (2008) (0)
mRNA expression profile of adipose tissue in HIV-1 positive subjects with art-related lipoatrophy (2011) (0)
Evolution and Determinants of the Prevalence of HCV Infection and Hcv Genotype Distribution among Hivinfected Patients Entering in Care between 1997–2015 in Italy: Data from a Prospective Nationwide Cohort (ICONA) (2016) (0)
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort. (2021) (0)
High Mortality Rate Among Latin American Immigrants With Covid-19 Hospitalised in Milan, Italy: Data From the Luigi Sacco Hospital Registry (2021) (0)
P.07.10 PHYSICIANS' KNOWLEDGE AND APPLICATION OF IMMUNIZATION STRATEGIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SURVEY BY THE ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD) (2019) (0)
Hepatitis C virus and cryoglobulinemia : proceedings of a meeting held in Milan, Italy, 13-14 October 1994 (1995) (0)
HBV/HCV Co-infection and Mixed Cryoglobulinemia (2012) (0)
INFANT FEEDING MODALITIES AND MORBIDITY IN HIV INFECTED WOMEN IN RESOURCE-POOR COUNTRIES. A MULTICENTER STUDY IN SUBSAHARAN AFRICA (2009) (0)
Therapy with high dosed immunoglobulins in patients with correlated HIV and thrombocytopenia (1987) (0)
Absence of antinuclear antibodies in cryoprecipitates of patients with essential mixed or secondary non-lupoid cryoglobulinemia (1986) (0)
The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis and Panoptosis. (2023) (0)
Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort (2016) (0)
Hepatitis C Virus: Determinants Of Patients’ Management Costs (2017) (0)
Striking changes of miRNAs expression in peripheral CD4+ T lymphocytes from HIV-1 infected and HIV-1 exposed uninfected people (2010) (0)
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens (2014) (0)
Chapter 2 HBV Virus in the Future (2019) (0)
Spatial and Temporal Analyses of the Event of Death for 1480 in Milan Using the Data Contained in the Sforza’s Registers of the Dead (2023) (0)
Time And Mode Of Epidemic Hcv-2 Subtypes Dispersal In Europe: Phylodynamics Of Hcv-2c In Italy And Albania (2021) (0)
Comment on: Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. (2017) (0)
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS (2019) (0)
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects. (2002) (0)
Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients (2008) (0)
Legionellosis Complicated by Invasive Aspergillosis in a Patient With Rheumatoid Arthritis. (2020) (0)
PIN23 To Assess or Not To Assess: That is the Question! Budget, Ethical and Decisional Impact assessment in HIV: Lombardy Region's Molo Project (2011) (0)
Higher expression of Adiponectin Q and lower expression of enhancer binding protein alpha in adipose tissue characterize HIV-1 infected patients with lypodystrophy (2011) (0)
Durability of lopinavir/r monotherapy in people with viral load ≤50 copies/Ml (2012) (0)
Electrophysiologic pattern and T-cell subsets in Bell's palsy. (1994) (0)
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon]. (1985) (0)
Epidemiological spread of drug-resistant HIV-1 strains. (2001) (0)
Lymphocyte subpopulation dynamic and natural history of HIV-1 infection (1997) (0)
Acute Coronary Syndromes and COVID-19: Exploring the Dark Side of the Outbreak (2020) (0)
Analyses of Pre-erythroid cells in peripheral blood of patients with different progression of HIV infection (2015) (0)
Darunavir exhibits a potent activity as boosted PI in subjects on a salvage antiretroviral regimen (2008) (0)
RNA Viruses and Autoimmunity: A Short Overview (2018) (0)
O-16 Resting-state functional cortical connectivity are abnormal in HIV patients (2019) (0)
Patients with Inflammatory Bowel Disease Have a Lower Risk of COVID-19: A Case-Control Study from Lombardy, Italy (2020) (0)
Tuberculous meningitis in a patient with acute human immunodeficiency virus infection. (2010) (0)
P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIA (2014) (0)
P801 Physicians’ knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD) (2019) (0)
Mixed Schistosoma infection in an asymptomatic patient. (1985) (0)
Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors (2017) (0)
Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Massimo Galli?

Massimo Galli is affiliated with the following schools:

University of Milan